SCHEMBL2159176

SCHEMBL2159176

Cn1c(C(=N)NO)nc2cc(F)ccc21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 2/20 0.41
▸ RAB9A P51151 2/20 0.41
▸ MAPT P10636 1/20 0.41
▸ ATM Q13315 1/20 0.41
▸ HDAC6 Q9UBN7 5/20 0.41
▸ MEN1 O00255 1/20 0.38
▸ HCRTR1 O43613 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ POLB P06746 1/20 0.38
▸ KDM4E B2RXH2 1/20 0.37
▸ ALDH1A1 P00352 1/20 0.37
▸ HPGD P15428 1/20 0.37
▸ HSD17B10 Q99714 1/20 0.37
▸ HDAC1 Q13547 2/20 0.36
▸ PDE10A Q9Y233 1/20 0.36
▸ PCSK9 Q8NBP7 2/20 0.36
▸ HTR3E A5X5Y0 1/20 0.35
▸ HTR3B O95264 1/20 0.35
▸ HTR3A P46098 1/20 0.35
▸ HTR3D Q70Z44 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2158194 0.88 PCSK9 (0.46) NPC1RAB9AMAPTMEN1HCRTR1
SCHEMBL2857716 0.76 NPC1 (0.46) NPC1RAB9AMAPTATMHDAC6
SCHEMBL2159173 0.73 ALDH1A1 (0.40) NPC1RAB9AMAPTATMMEN1
SCHEMBL2159170 0.73 ALDH1A1 (0.40) NPC1RAB9AMAPTATMMEN1
SCHEMBL2711754 0.73 NPC1 (0.45) NPC1RAB9AMAPTATMHDAC6
SCHEMBL25080562 0.71 NPC1 (0.44) NPC1RAB9AMAPTATMHDAC6
SCHEMBL8052547 0.71 RAB9A (0.59) NPC1RAB9AMAPTATMMEN1
Hydrochloric Acid SCHEMBL28501510 0.70 KDM4E (0.43) NPC1RAB9AMAPTATMHDAC6
SCHEMBL19453691 0.70 ALDH1A1 (0.44) NPC1RAB9AMAPTATMMEN1
SCHEMBL8229995 0.70 NPC1 (0.43) NPC1RAB9AMAPTATMHDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110183974-A1 1,2,4-OXADIAZOLE SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES AS SMO ANTAGONISTS INSTITUTO DI RICERCHE DI BIOLOGIA MOLECOLARE P. ANGELETTI (IT) 2011-07-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110183974-A1 1,2,4-OXADIAZOLE SUBSTITUTED PIPERIDINE AND PIPERAZINE DERIVATIVES AS SMO ANTAGONISTS SHH, SMO, GLI1 NPC1 2688/4885RAB9A 2234/4885MAPT 883/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback